Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment

Chemotherapy-induced memory loss (“chemobrain”) can occur following treatment with the widely used chemotherapeutic agent doxorubicin (DOX). However, the mechanisms through which DOX induces cognitive dysfunction are not clear, and there are no commercially available therapies for its treatment or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhowail, Ahmad H., Eggert, Matthew, Bloemer, Jenna, Pinky, Priyanka D., Woodie, Lauren, Bhattacharya, Subhrajit, Bhattacharya, Dwipayan, Buabeid, Manal A., Smith, Bruce, Dhanasekaran, Muralikrishnan, Piazza, Gary, Reed, Miranda N., Escobar, Martha, Arnold, Robert D., Suppiramaniam, Vishnu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637675/
https://www.ncbi.nlm.nih.gov/pubmed/37948406
http://dx.doi.org/10.1371/journal.pone.0294280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637675/
https://www.ncbi.nlm.nih.gov/pubmed/37948406
http://dx.doi.org/10.1371/journal.pone.0294280

Ejemplares similares